Merck & Co. Inc. (NYSE: MRK) will pay a premium of approximately $3.85 billion in cash to acquire Idenix Pharmaceuticals Inc. (Nasdaq: IDIX). Shares of Idenix jumped $16.74 to $23.97 while Merck stock eased 4 cents to $57.81.
Merck to acquire Idenix Pharmaceuticals
June 09, 2014 at 14:40 PM EDT
